Alternatives to Umlaut.bio

Umlaut.bio is a Biotechnology tool: developing novel immunotherapies for cancer. Here are the 51 closest alternatives, compared on pricing, features and what real users say.

Umlaut.bio profile More Biotechnology alternatives

The 20 closest Biotechnology companies to Umlaut.bio

ImmunoScape
Not rated
Developing novel immunotherapies and diagnostics for cancer.
Visit site
ImmunityBio
Not rated
A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Visit site
GE
Genexine
Not rated
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
Visit site
Janux Therapeutics
Not rated
A clinical-stage biopharmaceutical company developing novel immunotherapies.
Visit site
Enterome
Not rated
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Visit site
Tharimmune
Not rated
Biotechnology company developing novel immunotherapies for cancer.
Visit site
Aptevo Therapeutics Inc.
Not rated
A clinical-stage biotechnology company developing novel bispecific and trispecific immunotherapies for the treatment of cancer.
Visit site
TG Therapeutics
Not rated
A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.
Visit site
Aummune
Not rated
Develops a platform for individual drug customization using aptamers for cancer treatment.
Visit site
Biomica
Not rated
Biomica is developing a novel microbiome-based platform for the treatment of cancer.
Visit site
Ella Therapeutics
Not rated
Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
Visit site
Nectin Therapeutics
Not rated
Biotech company developing next-generation immunotherapy agents to unlock the immune system.
Visit site
BioNTech
Not rated
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Visit site
KaliVir Immunotherapeutics, Inc.
5.0 out of 5 (1)
Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Visit site
CR
Crossbow Therapeutics
Not rated
Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.
Visit site
Waypoint Bio
Not rated
AI-native biotech company designing next-generation CAR T therapies for solid tumors.
Visit site
LTZ Therapeutics
Not rated
Immunotherapy company targeting oncology and autoimmune diseases.
Visit site
Signadori Bio
Not rated
Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
Visit site
Adaptimmune Therapeutics
Not rated
Biopharmaceutical company developing T-cell therapies for solid tumor cancers.
Visit site
Moderna
2.5 out of 5 (2)
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Visit site

Company	Rating	Visit
ImmunoScapeDeveloping novel immunotherapies and diagnostics for cancer.	Not rated	Visit site
ImmunityBioA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.	Not rated	Visit site
GEGenexineSouth Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.	Not rated	Visit site
Janux TherapeuticsA clinical-stage biopharmaceutical company developing novel immunotherapies.	Not rated	Visit site
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.	Not rated	Visit site
TharimmuneBiotechnology company developing novel immunotherapies for cancer.	Not rated	Visit site
Aptevo Therapeutics Inc.A clinical-stage biotechnology company developing novel bispecific and trispecific immunotherapies for the treatment of cancer.	Not rated	Visit site
TG TherapeuticsA commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.	Not rated	Visit site
AummuneDevelops a platform for individual drug customization using aptamers for cancer treatment.	Not rated	Visit site
BiomicaBiomica is developing a novel microbiome-based platform for the treatment of cancer.	Not rated	Visit site
Ella TherapeuticsDeveloping microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.	Not rated	Visit site
Nectin TherapeuticsBiotech company developing next-generation immunotherapy agents to unlock the immune system.	Not rated	Visit site
BioNTechGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.	Not rated	Visit site
KaliVir Immunotherapeutics, Inc.Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.	5.0 out of 5 (1)	Visit site
CRCrossbow TherapeuticsDeveloping TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.	Not rated	Visit site
Waypoint BioAI-native biotech company designing next-generation CAR T therapies for solid tumors.	Not rated	Visit site
LTZ TherapeuticsImmunotherapy company targeting oncology and autoimmune diseases.	Not rated	Visit site
Signadori BioDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.	Not rated	Visit site
Adaptimmune TherapeuticsBiopharmaceutical company developing T-cell therapies for solid tumor cancers.	Not rated	Visit site
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	2.5 out of 5 (2)	Visit site

Showing the next 20 closest matches. See the rest on the Umlaut.bio profile.

Sponsored rows are paid and labelled. Advertise on this page